Results 121 to 130 of about 8,261 (192)

Differential functional immune recall across homologous and heterologous COVID-19 vaccination regimens. [PDF]

Front Immunol
Che-Kamaruddin N, Johari J, Yahaya H, Zainal N, Nguyen HC, Hontz RD, Letizia AG, AbuBakar S.   +7 more
europepmc   +1 more source

CoronaVac Aşısı Olan Sağlıklı Bireylerde Koroidin Değerlendirilmesi: Optik Koherans Tomografi Çalışması

Amaç: COVID-19 nedeniyle CoronaVac aşısı uygulanan sağlıklı bireylerde koroidin yapısal ve vasküler parametrelerini değerlen- dirmek. Gereç ve Yöntem: İleriye yönelik dizayndaki bu çalışmaya sağlıklı 45 kişi dahil edildi.
TOKLU, Yasin, YORGUN, Mücella ARIKAN, İÇÖZ, Mehmet, İÇÖZ, Şule Gökçek GÜRTÜRK, TAŞÇI, Yelda YILDIZ, SARITAŞ, Özge   +5 more
core  

Adverse Events in Following Immunization with Inactivated SARS-CoV-2 Vaccines (TURKOVAC and CoronaVac) in PCR-Positive Asymptomatic or Mildly Symptomatic Individuals Compared to PCR-Negative Recipients. [PDF]

Vaccines (Basel)
Kara A, Ateş İ, Tekcan S, Uysal S, Aydoğmuş YH, Tanrıöver MD, Özdarendeli A, Oz E, Demirkol ME.   +8 more
europepmc   +1 more source

Analysis of Antibody Responses of Vaccinated Persons with Coronavac

Archives of Microbiology & Immunology, 2023
Aydin BALCI, Muhammed Emin DÜZ, Sibel Günay   +2 more
openaire   +1 more source

Optimizing COVID-19 vaccination for older adults: superior efficacy of heterologous regimens in reducing infection and mortality rates among patients aged 80 years and older during the Omicron BA.5/BF.7 outbreak. [PDF]

BMC Infect Dis
Qiu S, Chen Y, Sheng A, Shen B, He S, Zheng Y.   +5 more
europepmc   +1 more source

Safety, immunogenicity, and long COVID outcomes following inactivated COVID-19 vaccine boosters in elderly Chinese: a prospective cohort study. [PDF]

Front Immunol
Dai R, Hua Q, Liu X, Ma L, Bao R, Lei H, Yu P, Liao Y, Yang J, Han S, Jiang J, Zhang H.   +11 more
europepmc   +1 more source

Heterologous RBMRNA-405 mRNA booster enhances humoral immunity post-inactivated COVID-19 vaccination: a randomized clinical trial in adults and older through 12 months. [PDF]

Sci Rep
Yong X, He J, Zhang C, Wang Y, Ou Y, Zhang B.   +5 more
europepmc   +1 more source

Effectiveness of CoronaVac in a pioneer risk-based allocation clinical trial during the COVID-19 pandemic. [PDF]

PLoS One
Martins A, Bosco Santos MF, Nascimento J, da Silva Chui FM, Almeida Rodrigues MG, Bastos T, Lemos S, Honorato E, Cortez M, Xavier MS, Gomes EO, Abreu-Netto RL, Fernandes S, Silva-Neto AV, Sachett A, Silva BM, Mouta GS, Cordeiro JSM, Baía-da-Silva DC, Brito-Sousa JD, Pessoa KP, Nogueira ML, Palacios R, Monteiro W, Naveca F, Sampaio V, Almeida-Val F, Melo G, Ranzani O, Mourão MP, Lacerda M.   +30 more
europepmc   +1 more source

Four doses of coronavirus disease 2019 vaccination for patients with inborn errors of immunity compared to 3 doses for healthy individuals. [PDF]

J Allergy Clin Immunol Glob
Chan JCH, Cheng SMS, Leung D, Wang X, Wang M, Cheuk YC, Ho C, Tsang LCH, Kwan TC, Lee AMT, Li WY, Lam JHY, Zhang K, Tam IYS, Chan SM, Chan KW, Peiris M, Tu W, Lau YL, Rosa Duque JS.   +19 more
europepmc   +1 more source

Reply to Mungmunpuntipantip and Wiwanitkit: CoronaVac or BNT162b2 Vaccine as a Third Dose

American Journal of Respiratory and Critical Care Medicine, 2022
Chris Ka Pun Mok, David S. Hui, Malik Peiris   +2 more
openaire   +2 more sources